Atlas Trials

Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer

Clinical trial NCT00960336 · COMPLETED

Trial details

NCT number
NCT00960336
Sponsor
ARCAGY/ GINECO GROUP
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2008-03-01
Primary completion
2011-05-01
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.